siRNA applications in nanomedicine

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 3, 2010, Pages 305-315

  Tokatlian, Talar ^a   Segura, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATIONIC LIPIDS; CATIONIC POLYMERS; CYTOSOLS; DIRECT MODIFICATION; GENE SILENCING; IN-VIVO; INTRACELLULAR TRAFFICKING; MACRO SCALE; NANO-SIZED PARTICLES; NANOMEDICINES; RNA INTERFERENCE; RNA-INDUCED SILENCING COMPLEXES; SELF-ASSEMBLED; SIRNA DELIVERY; SMALL INTERFERING RNA (SIRNA); SPECIFIC BINDING; THERAPEUTIC APPLICATION; THERAPEUTIC DRUGS; TISSUE FORMATION;

GENETIC ENGINEERING; LIPOSOMES; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PHOSPHOLIPIDS;

RNA;

LIPID; LIPOSOME; NANOPARTICLE; POLYMER; SMALL INTERFERING RNA;

DRUG DELIVERY SYSTEM; DRUG TRANSPORT; GENE SILENCING; HUMAN; NANOMEDICINE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

ANIMALS; HUMANS; NANOMEDICINE; RNA, SMALL INTERFERING;

EID: 77953678900     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.81     Document Type: Review

References (54)

1. Reischl D, Zimmer A. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomed Nanotechnol Biol Med 2009, 5(1):8-20.
2. Bertrand J-R, Pottier M, Vekris A, Opolon P, Maksimenko A, et al. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002, 296:1000-1004.
3. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001, 15:188-200. (Pubitemid 32107664)
4. Akhtar S, Benter IF. Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 2007, 117:3623-3632. (Pubitemid 350224068)
5. Takahashi Y, Nishikawa M, Takakura Y. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Adv Drug Deliv Rev 2009, 61:760-766.
6. Yao Y, Wang C, Varshney RR, Wang DA. Anti-sense makes sense in engineered regenerative medicine. Pharm Res 2009, 26:263-275.
7. Choudhuri S. Lesser known relatives of miRNA. Biochem Biophys Res Commun 2009, 388: 177-180.
8. Manjunath N, Wu H, Subramanya S, Shankar P. Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev 2009, 61:732-745.
9. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178. (Pubitemid 39545841)
10. Zimmermann TS, Lee ACH, Akinc A, Bramlage B, Bumcrot D, et al. RNAi-mediated gene silencing in non-human primates. Nature 2006, 441:111-114. (Pubitemid 43827961)
11. Bolcato-Bellemin AL, Bonnet ME, Creusat G, Erbacher P, Behr JP. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci U S A 2007, 104:16050-16055. (Pubitemid 350099361)
12. De Paula D, Bentley MV, Mahato RI. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA 2007, 13:431-456. (Pubitemid 46509424)
13. Moschos SA, Jones SW, Perry MM, Williams AE, Erjefalt JS, et al. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem 2007, 18:1450-1459.
14. Kim WJ, Kim SW. Efficient siRNA delivery with non-viral polymeric vehicles. Pharm Res 2009, 26: 657-666.
15. Schaffert D, Wagner E. Gene therapy progress and prospects: synthetic polymer-based systems. Gene Ther 2008, 15:1131-1138.
16. He XW, Liu T, Xiao Y, Feng YL, Cheng DJ, et al. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo. Cancer Biother Radiopharm 2009, 24: 249-259. (Pubitemid 351240670)
17. Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer JK, Wood MJ, et al. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 2009, 8:526-533.
18. Rozema DB, Lewis DL, Wakefield DH,Wong SC, Klein JJ, et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A 2007, 104:12982-12987. (Pubitemid 351737577)
19. Heidel JD, Yu Z, Liu JY, Rele SM, Liang Y, et al. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc Natl Acad Sci U S A 2007, 104:5715-5721. (Pubitemid 47175600)
20. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A 2007, 104:15549-15554. (Pubitemid 47502954)
21. Pirollo KF, Chang EH. Targeted delivery of small interfering RNA: approaching effective cancer therapies. Cancer Res 2008, 68:1247-1250.
22. Muratovska A, Eccles MR.Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS lett 2004, 558(1):63-68. (Pubitemid 38167411)
23. Oliveira S, van Rooy I, Kranenburg O, Storm G, Schiffelers RM. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int J Pharm 2007, 331:211-214. (Pubitemid 46216677)
24. Hatakeyama H, Ito E, Akita H, Oishi M, Nagasaki Y, Futaki S, Harashima H. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Control Release 2009, 139:127-132.
25. Convertine AJ, Benoit DSW, Duvall CL, Hoffman AS, Stayton PS. Development of a novel endosomolytic diblock copolymer for siRNA delivery. J Control Release 2009, 133:221-229.
26. Rao DD, Vorhies JS, Senzer N, Nemunaitis J. siRNA vs. shRNA: similarities and differences. Adv Drug Deliv Rev 2009, 61:746-759.
27. Lee H, Mok H, Lee S, Oh YK, Park TG. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release 2007, 119:245-252. (Pubitemid 46754507)
28. Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 2008, 319:627-630. (Pubitemid 351197066)
29. Jere D, Arote R, Jiang HL, Kim YK, Cho MH, et al. Bioreducible polymers for efficient gene and siRNA delivery. Biomed Mater 2009, 4:25020.
30. Shim MS, Kwon YJ. Acid-responsive linear polyethylenimine for efficient, specific, and biocompatible siRNA delivery. Bioconjug Chem 2009, 6:6.
31. Midoux P, Pichon C, Yaouanc JJ, Jaffres PA. Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol 2009, 157:166-178.
32. Lu JJ, Langer R, Chen J. A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol Pharm 2009, 6:763-771.
33. Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol 2006, 124(1): 12-25. (Pubitemid 43816129)
34. Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, et al.Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 2007, 25:1149-1157. (Pubitemid 47538115)
35. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005, 12:461-466. (Pubitemid 40394299)
36. Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Buyens K, et al. Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g- poly( ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by fluorescence fluctuation spectroscopy and single photon emission computed tomography (SPECT) imaging. J Control Release 2009, 138:148-159.
37. Crombez L, Morris MC, Dufort S, Aldrian-Herrada G, Nguyen Q, et al. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res 2009, 37:4559-4569.
38. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, et al. A combinatorial library of lipidlike materials for delivery of RNAi therapeutics. Nat Biotechnol 2008, 26:561-569. (Pubitemid 351668042)
39. Yagi N, Manabe I, Tottori T, Ishihara A, Ogata F, et al. A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo. Cancer Res 2009, 69:6531-6538.
40. Bradley SP, Rastellini C, da Costa MA, Kowalik TF, Bloomenthal AB, et al. Gene silencing in the endocrine pancreas mediated by short-interfering RNA. Pancreas 2005, 31:373-379. (Pubitemid 41566888)
41. Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, et al. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther 2007, 14:752-759. (Pubitemid 46585656)
42. 2- thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc 2005, 127:1624-1625.
43. Segura T, Schmokel H, Hubbell JA. RNA interference targeting hypoxia inducible factor 1[alpha] reduces post-operative adhesions in rats. J Surg Res 2007, 141:162-170. (Pubitemid 47042044)
44. Oh Y-K, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009, 61:850-862.
45. Crombez L, Aldrian-Herrada G, Konate K, Nguyen QN, McMaster GK, et al. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther 2009, 17(1):95-103.
46. Eguchi A, Meade BR, Chang Y-C, Fredrickson CT, Willert K, et al. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat Biotechnol 2009, 27:567-571.
47. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA. Gene regulation with polyvalent siRNAâ 'nanoparticle conjugates. J Am Chem Soc 2009, 131:2072-2073.
48. Elbakry A, Zaky A, Liebl R, Rachel R, Goepferich A, et al. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 2009, 9:2059-2064.
49. Cheema SK, Chen E, Shea LD, Mathur AB. Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair Regen 2007, 15:286-295. (Pubitemid 46817403)
50. Krebs MD, Jeon O, Alsberg E. Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. J Am Chem Soc 2009, 131:9204-9206.
51. Jang J-H, Houchin TL, Shea LD. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Dev 2004, 1(1):127-138. (Pubitemid 40220424)
52. Hlawaty H, San Juan A, Jacob MP, Vranckx R, Letourneur D, et al. Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection. J Gene Med 2009, 11(1):92-99.
53. Manrique C, Compan V, Rosselet C, Duflo SGD. Specific knock-down of GAD67 in the striatum using naked small interfering RNAs. J Biotechnol 2009, 142:185-192.
54. Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada H. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Control Release 2008, 126:246-254.